IL-17A induces valvular endothelial inflammation and aggravates calcific aortic valve disease
- 25 May 2023
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 672, 145-153
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81870263)
- Natural Science Foundation of Beijing Municipality (7232012)
This publication has 26 references indexed in Scilit:
- P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: Implication for calcific aortic valve diseaseJournal of Molecular and Cellular Cardiology, 2014
- Guidelines on the management of valvular heart disease (version 2012)European Heart Journal, 2012
- Epidemiology of valvular heart disease in the adultNature Reviews Cardiology, 2011
- A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in MiceThe Journal of Immunology, 2010
- Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient MiceThe Journal of Immunology, 2009
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cellsNature Immunology, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse modelBMC Cardiovascular Disorders, 2009
- Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the ElderlyNew England Journal of Medicine, 1999
- Anatomic Heterogeneity of Vascular AgingHypertension, 1997